Eroğlu I - Search Results

1

Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer.

Önal Ö, Koçer M, Eroğlu HN, Yilmaz SD, Eroğlu I, Karadoğan D. Önal Ö, et al. Among authors: eroglu i, eroglu hn. Turk J Med Sci. 2020 Dec 17;50(8):1838-1850. doi: 10.3906/sag-1912-205. Turk J Med Sci. 2020. PMID: 32512671 Free PMC article.

2

Serum zonulin levels in type 2 diabetes patients with diabetic kidney disease.

Sirin FB, Korkmaz H, Eroglu I, Afsar B, Kumbul Doguc D. Sirin FB, et al. Among authors: eroglu i. Endokrynol Pol. 2021;72(5):545-549. doi: 10.5603/EP.a2021.0056. Epub 2021 May 31. Endokrynol Pol. 2021. PMID: 34057189 Free article.

3

New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.

Eroglu İ, Korkmaz H, Ozturk KH, Sirin FB, Sevik S, Afsar B. Eroglu İ, et al. Minerva Endocrinol (Torino). 2022 Sep;47(3):314-324. doi: 10.23736/S2724-6507.20.03204-6. Epub 2020 Dec 17. Minerva Endocrinol (Torino). 2022. PMID: 33331738

4

Carcinoma erysipeloides, a case-report and review of the sixty-nine cases in the literature.

Eroğlu İ, Üner A, Gürler F, Yazıcı O, Özet A, Özdemir N. Eroğlu İ, et al. Am J Med Sci. 2024 Oct 24:S0002-9629(24)01511-8. doi: 10.1016/j.amjms.2024.10.008. Online ahead of print. Am J Med Sci. 2024. PMID: 39454728

5

Therapeutic targeting of siRNA/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA/5-FU loaded liposome nanocomplexes.

Aslan M, Ozturk S, Shahbazi R, Bozdemir Ö, Dilara Zeybek N, Vargel İ, Eroğlu İ, Ulubayram K. Aslan M, et al. Among authors: eroglu i. Eur J Pharm Biopharm. 2024 Oct;203:114432. doi: 10.1016/j.ejpb.2024.114432. Epub 2024 Aug 2. Eur J Pharm Biopharm. 2024. PMID: 39097115

6

Production of 5-fluorouracil-loaded PLGA nanoparticles with toroidal microfluidic system and optimization of process variables by design of experiments.

Turkmen Koc SN, Conger E, Ozturk S, Eroglu I, Ulubayram K. Turkmen Koc SN, et al. Among authors: eroglu i. Int J Pharm. 2024 Sep 5;662:124501. doi: 10.1016/j.ijpharm.2024.124501. Epub 2024 Jul 23. Int J Pharm. 2024. PMID: 39053677

7

Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.

Pilewskie M, Eroglu I, Sevilimedu V, Le T, Mangino D, Morrow M. Pilewskie M, et al. Among authors: eroglu i. Ann Surg Oncol. 2024 Oct;31(10):6764-6773. doi: 10.1245/s10434-024-15633-x. Epub 2024 Jun 29. Ann Surg Oncol. 2024. PMID: 38949720

8

The effect of hand-foot exercises on chemotherapy-induced peripheral neuropathy-related pain, falls, and quality of life in colorectal cancer: A randomized controlled trial.

Eroğlu İ, Kutlutürkan S. Eroğlu İ, et al. Eur J Oncol Nurs. 2024 Aug;71:102641. doi: 10.1016/j.ejon.2024.102641. Epub 2024 Jun 15. Eur J Oncol Nurs. 2024. PMID: 38897103 Clinical Trial.

9

Muscle function, exercise capacity, physical activity level and cardiovascular disease risk factor knowledge in patients with prolactinoma.

Erkoç A, Eroğlu İ, Erbas T, Kutukcu EC. Erkoç A, et al. Among authors: eroglu i. Endocrine. 2024 Sep;85(3):1337-1345. doi: 10.1007/s12020-024-03880-7. Epub 2024 May 27. Endocrine. 2024. PMID: 38801597

10

Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study.

Eroğlu İ, Iremli BG, Erkoc A, Idilman IS, Yuce D, Kutukcu EC, Akata D, Erbas T. Eroğlu İ, et al. J Clin Densitom. 2024 Apr-Jun;27(2):101479. doi: 10.1016/j.jocd.2024.101479. Epub 2024 Feb 22. J Clin Densitom. 2024. PMID: 38447349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters